Cornel Imhof

Title: Cornel Imhof: Innovator in Collagen Technology

Introduction

Cornel Imhof is a notable inventor based in Luzern, Switzerland. He has made significant contributions to the field of biomedical materials, particularly in the development of innovative collagen-based products. His work focuses on enhancing soft tissue augmentation techniques, which are crucial in various medical applications.

Latest Patents

Cornel Imhof holds a patent for a resilient resorbable chemically crosslinked collagen sponge. This innovative sponge is designed for promoting soft tissue volume augmentation in the oral region. The sponge comprises 60-96% (w/w) collagen and 4-40% (w/w) elastin. It features interconnected pores with a median pore diameter between 50 and 90 µm and at least 80% porosity with a pore diameter greater than 10 µm. The sponge has an onset temperature of 45 to 57°C and a density in the dry state ranging from 50 to 65 mg/cm. Additionally, he has developed a process for preparing this collagen sponge and a method for using it as an implant in the oral cavity.

Career Highlights

Cornel Imhof is associated with Geistlich Pharma AG, a company renowned for its advancements in regenerative medicine and dental solutions. His work at Geistlich Pharma AG has positioned him as a key player in the development of innovative medical products that enhance patient outcomes.

Collaborations

Throughout his career, Cornel has collaborated with esteemed colleagues such as Lothar Schloesser and Niklaus Stiefel. These collaborations have further enriched his research and development efforts in the field of collagen technology.

Conclusion

Cornel Imhof's contributions to collagen technology exemplify the impact of innovative thinking in the medical field. His patented collagen sponge represents a significant advancement in soft tissue augmentation, showcasing his dedication to improving medical solutions.